Stockreport

BELLUS Health Announces Completion of Dosing in Phase 2 RELIEF Trial with BLU-5937 for the Treatment of Refractory Chronic Cough

BELLUS Health Inc. - Common Shares  (BLU) 
Last bellus health inc. - common shares earnings: 11/14 07:00 am Check Earnings Report
PDF - Topline data on track for mid-year 2020 - LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (the “Company” or “BELLUS Health”) , a clinical [Read more]